HOME>Investors>Governance>Board of Directors
-
Composition
2022 BOD Composition
As of Jun. 30, 2022
이사회 구성 현황표 Inside Directors -
- ●
- Min-Young Kim(CEO)
-
- Appointed : March 28, 2022
- Term : 3 years
- CEO, Dong-A ST
- B.A. in Business Administration,
Seoul National Univ.
-
- ●
- Jae-Hong Park
-
- Appointed : March 28, 2022
- Term : 3 years
- President, Dong-A ST
- Harvard Medical School : Institute of
Proteomics Postdoctoral Fellow
-
- ●
- Sung-Keun Lee
-
- Appointed : March 24, 2020
- Term : 3 years
- Executive Director & CFO (KICPA)
- B.A in Business Administration, Sogang University
Outside Directors -
- ●
- Hee-Joo Choi(Chairman)
-
- Appointed : March 24, 2021
- Term : 3 years
- Senior Advisor in Yulchon LLC.
- Head of Office for Population Policy,
Ministry of Health & Welfare
-
- ●
- Hak-Jun Kim
-
- Appointed : March 24, 2020
- Term : 3 years
- CEO, PA-Partners administrative affairs
- Master of, Social Pharmacology Sungkyunkwan University
-
- ●
- Jae-Sang Ryu
-
- Appointed : March 24, 2021
- Term : 3 years
- Professor, Department of Pharmacy,
Ewha Womans Univ. - Postdoctoral Fellow, Memorial Sloan-Kettering Cancer Center.
-
- ●
- Bum-Joon Kim
-
- Appointed : March 28, 2022
- Term : 3 years
- Professor, The Catholic University of Korea
- Member, Statutory Interpretation and Deliberation Committee,
Financial Services Commission
-
-
Operation
2022 BOD Operation
As of Jun. 30, 2022
주식분포 상황 표 No. Date Agenda Recognition Name of Outside Directors Hee-
Joo
ChoiJae-
Sang
RyuHak-
Jun
KimBum-
Joon
KimKeun-
Soo
KimAgree/Disagree 1 2022.01.07 Extension of debt Approved Agree Agree Agree - Agree 2 2022.01.21 Extension of debt Approved Agree Agree Agree - Agree 3 2022.02.11 Approval of 9th term settlement documents (separated) Approved Agree Agree Agree - Agree 4 2022.02.18 Approval of 8th term settlement documents (separated) Approved Agree Agree Agree - Agree 5 2022.02.25 Report 2021 financial results and 2022 financial plan Reported Attended Attended Attended - Attended Approval of 9th term settlement documents (consolidated) Approved Agree Agree Agree - Agree Audit Committee’s Report on the evaluation of the operational status of the Internal Accounting Management System Reported Attended Attended Attended - Attended Report on result of 2021 CEO’s ISO37001 review Reported Attended Attended Attended - Attended Report on the ESG evaluation and operation status for 2021 Reported Attended Attended Attended - Attended Convening of the 9th annual meeting of shareholders Approved Agree Agree Agree - Agree Pre-approval of the scale of transactions with related parties Approved Agree Agree Agree - Agree 6 2022.03.21 Approval of private placement bond issue Approved Agree Agree Agree - Agree Approval of new borrowings Approved Agree Agree Agree - Agree 7 2022.03.28 Appointment of CEO Approved Agree Agree Agree Agree - Reorganization of BOD Committees Approved Agree Agree Agree Agree - 2021 BOD Operation
As of Dec. 31, 2021
주식분포 상황 표 No. Date Agenda Recognition Name of Outside Directors Keun-
Soo
KimJae-
Sang
RyuHee-
Joo
ChoiHak-
Jun
KimAgree/Disagree 1 2021.01.15 Extension of debt Approved Agree Agree Agree Agree 2 2021.02.01 Approval of 8th term settlement documents (separated) Approved Agree Agree Agree Agree 3 2021.02.17 Report on the operational status of the Internal Accounting Management System Approved Agree Agree Agree Agree Approval of 8th term settlement documents (consolidated) Approved Agree Agree Agree Agree 4 2021.02.22 establishment of an R&D center Approved Agree Agree Agree Agree 5 2021.02.26 Report 2020 financial results and 2021 financial plan Reported Attended Attended Attended Attended Audit Committee’s Report on the evaluation of the operational status of the Internal Accounting Management System Reported Attended Attended Attended Attended Report on result of 2020 CEO’s ISO37001 review Reported Attended Attended Attended Attended Convening of the 7th annual meeting of shareholders Approved Agree Agree Agree Agree Pre-approval of the scale of transactions with related parties Approved Agree Agree Agree Agree 6 2021.03.24 Appointment of a BOD’s Chairman Approved Agree Agree Agree Agree Appointment of a representative director Approved Agree Agree Agree Agree Reorganization of BOD Committees Approved Agree Agree Agree Agree 7 2021.04.05 Extension of debt Approved Agree Agree Agree Agree 8 2021.04.23 Report 2020 1st quarter Financial Results Reported Attended Attended Attended Attended 9 2021.05.10 Approval of new borrowings Approved Agree Agree Agree Agree Extension of debt Approved Agree Agree Agree Agree 10 2021.06.09 Issuance of convertible bonds Approved Agree Agree Agree Agree appointment of manager Approved Agree Agree Agree Agree 11 2021.07.30 Report 2021 2nd quarter Financial Results Reported Attended Attended Attended Attended Report on safety and health management plan of 2021 Reported Attended Attended Attended Attended Acquisition of Chammed shares Approved Agree Agree Agree Agree 12 2021.10.15 Dept Refinancing Approved Agree Agree Agree Agree 13 2021.10.22 Report 2021 3rd quarter Financial Results Reported Attended Attended Attended Attended Report on the results of the closed dialogue with the National Pension Service Reported Attended Attended Attended Attended 14 2021.12.02 Establishment of a subsidiary in India Approved Agree Agree Agree Agree